• Info
  • Insider Trading

Insider Transactions Reported by 11 Insiders of Strongbridge Biopharma plc

Location
Trevose, PA

There are no Buy or Sell transactions made by insiders since 26 Jan 2025

Strongbridge Biopharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fredric J. Cohen Chief Medical Officer $330,440 05 Oct 2021
Scott L. Wilhoit Chief Commercial Officer 05 Oct 2021
JEFFREY W. SHERMAN Director 05 Oct 2021
Garheng Kong Director 05 Oct 2021
CDK ASSOCIATES, L.L.C. 10%+ Owner 05 Oct 2021
Richard S. Kollender President and CFO 05 Oct 2021
JOHN JOHNSON Chief Executive Officer, Director 05 Oct 2021
DAVID N. GILL Director 05 Oct 2021
STEPHEN J. LONG Chief Legal Officer 05 Oct 2021
Hilde H. Steineger Director 05 Oct 2021
Marten Steen Director 05 Oct 2021

Recent Insider Transactions by Companies or Individuals for Strongbridge Biopharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.